Sun Pharma faces lawsuit for allegedly violating patents
Despite legal struggles, investors’ confidence remains strong in the pharma giant.
25 July, 2024•2 min
0
25 July, 2024•2 min
0

Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
SUBSCRIBE
Already have an account? Sign In
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Business
Business
Capgemini to acquire WNS for $3.3 billion in AI-driven expansion
The French IT services giant aims to create a leader in “intelligent operations” by combining AI capabilities with business process outsourcing expertise.
You may also like
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
Business
Natco just can’t kick its high-risk, high-gain game plan
CEO Rajeev Nannapaneni’s oft-used strategy of mounting patent challenges in the US got the pharma company its latest blockbuster Revlimid. But what after sales fall off a cliff?